Treatment of Metastatic Renal Cell Carcinoma

dc.contributor.authorRichter I.cs
dc.contributor.authorDvořák Josefcs
dc.date.accessioned2020-06-08T09:38:53Z
dc.date.available20-28-2019en
dc.date.available2020-06-08T09:38:53Z
dc.date.issued2018cs
dc.date.updated29-22-2019en
dc.format.extent7cs
dc.identifier.doi10.14735/amko2018110
dc.identifier.issn0862-495Xcs
dc.identifier.urihttps://dspace.tul.cz/handle/15240/155559
dc.language.isoczecs
dc.publisherAmbit Media, a.s.cs
dc.publisher.cityPrahacs
dc.relation.ispartofKlinicka Onkologieen
dc.relation.ispartofseries1cs
dc.subjectrenal cancercs
dc.subjecttargeted therapycs
dc.subjectimmunotherapycs
dc.subjectmetastasescs
dc.subjectbiomarkerscs
dc.titleTreatment of Metastatic Renal Cell Carcinomaen
dc.titleÚvod do problematiky léčby zhoubných nádoru ledvincs
local.citation.epage110-116cs
local.citation.spage110-116cs
local.identifier.publikace6163
local.relation.issue2cs
Files
Collections